Lisinopril and Bupropion Interaction: Safety, Risks, and Monitoring

Can you take lisinopril and bupropion together?

Yes, for most patients. There is no established pharmacokinetic drug interaction between lisinopril and bupropion. The concern that prescribers and pharmacists actually track is that bupropion can increase blood pressure in some patients, an effect described in the FDA-approved bupropion labeling, while lisinopril is prescribed specifically to lower blood pressure. That opposition in direction, not a metabolic clash, is the entire basis for calling this a "moderate" interaction in most drug interaction references. The practical response is blood pressure monitoring after starting or adjusting bupropion, not avoidance of the combination.

Why this pairing comes up often

Hypertension and depression are both common, and they overlap more than chance would predict, with shared pathways through sympathetic nervous system activity and hypothalamic-pituitary-adrenal axis regulation described in cardiovascular and endocrine literature. When a patient on lisinopril develops depression, or a patient already on bupropion for depression or smoking cessation is found to have elevated blood pressure, these two drugs end up on the same medication list.

Lisinopril is an ACE inhibitor approved for hypertension, heart failure, and post-myocardial infarction management. According to its FDA-approved prescribing information, it lowers blood pressure by blocking the conversion of angiotensin I to angiotensin II, which reduces vasoconstriction and aldosterone-driven sodium retention. Usual doses range from 5 mg to 40 mg daily.

Bupropion is a norepinephrine-dopamine reuptake inhibitor approved for major depressive disorder, seasonal affective disorder (as Wellbutrin XL), and smoking cessation (as Zyban). Per the FDA-approved bupropion label, it is metabolized primarily through CYP2B6 to an active metabolite, and both the parent drug and metabolite are inhibitors of CYP2D6. The label also identifies dose-related increases in blood pressure and seizure risk as safety concerns.

Why there is no meaningful metabolic interaction

Lisinopril is unusual among ACE inhibitors because it is not a prodrug. It enters the bloodstream already active, is not appreciably protein-bound, and is excreted unchanged by the kidneys according to its label. It does not undergo hepatic Phase I or Phase II metabolism, so no CYP450 enzyme is involved in its clearance.

Bupropion's clinically important interactions run through CYP2D6 inhibition, which matters for drugs that depend on that enzyme for clearance, such as certain beta-blockers, some antipsychotics, tamoxifen, and codeine. Because lisinopril never passes through a CYP-mediated pathway, bupropion's enzyme inhibition has no bearing on lisinopril blood levels. This is a structural, mechanism-based conclusion drawn directly from how each drug is eliminated, not from a specific interaction trial, and it is the strongest and most durable statement this page can make.

The real concern: blood pressure opposition

Bupropion increases synaptic norepinephrine and dopamine. Norepinephrine is a vasoconstrictor and increases heart rate, and the bupropion label lists blood pressure elevation, sometimes sustained, as an adverse effect that has occurred in clinical trials, particularly at higher doses. The label recommends blood pressure monitoring, especially in patients who are also taking other medications that affect blood pressure.

What is established: bupropion can raise blood pressure in a dose-related way in at least some patients, and this is a labeled effect rather than a rare anecdotal report.

The relationship between bupropion dose and blood pressure elevation remains incompletely characterized. Earlier versions of this page included specific values (such as a reported 6% hypertension incidence at 450 mg/day or millimeter-range systolic increases) drawn from the bupropion prescribing label and published cohort data. During this revision, these specific figures could not be verified through direct examination of primary sources and therefore should not be cited as established fact. Before republishing any quantitative claims about bupropion-related blood pressure changes, clinicians and pharmacists should independently review the current prescribing label and underlying cohort studies.

What is not established: that this interaction causes acute hypertensive crisis. Bupropion's blood pressure effect, where it occurs, has been described as gradual and dose-related rather than a sudden spike, which distinguishes it mechanistically from interactions involving MAO inhibitors or sympathomimetic overdose.

Seizure threshold: a separate question from blood pressure

Bupropion carries a labeled, dose-dependent seizure risk, which is why the FDA label sets a maximum recommended dose and cautions against exceeding it. Lisinopril has no established mechanism for lowering the seizure threshold. The only theoretical bridge between the two drugs is severe ACE-inhibitor-induced hyperkalemia, but seizures from hyperkalemia would require potassium levels far outside what routine lisinopril use produces in a patient with normal kidney function. In practice, seizure risk with bupropion is a bupropion-specific issue governed by dose, and by other seizure-lowering factors such as alcohol withdrawal, eating disorders, or concurrent use of other drugs that lower seizure threshold (tramadol and certain antipsychotics, for example), not by co-administration with lisinopril.

An evidence-status assessment for this interaction

Monitoring approach

There is no established formal monitoring protocol specific to this combination from a guideline body. A reasonable, conservative approach based on how each drug behaves:

• Check blood pressure before starting the second drug, so there is a true baseline.
• Have the patient take home readings for the first couple of weeks after starting or increasing bupropion, since that is when a blood pressure effect, if present, would appear.
• Recheck at a follow-up visit around 4 to 8 weeks after the change.
• If blood pressure has risen consistently above the patient's individualized target, options include increasing lisinopril within its approved dosing range, adding another antihypertensive, or considering an antidepressant with a more neutral blood pressure profile, per an American College of Cardiology/American Heart Association hypertension management approach of optimizing existing therapy before adding new drug classes.
• Continue routine annual monitoring of serum potassium and creatinine, standard for anyone on an ACE inhibitor, regardless of bupropion use.

Special populations

Older adults may be more sensitive to blood pressure changes and more likely to experience symptoms such as dizziness or falls if blood pressure rises or fluctuates. This warrants closer monitoring when adding bupropion in this group, though it reflects general geriatric prescribing caution rather than a documented lisinopril-specific concern.

Chronic kidney disease: lisinopril dosing needs adjustment as kidney function declines, per its label, and bupropion and its metabolites can accumulate when kidney function is reduced, per the bupropion label, which recommends reduced dosing frequency in significant renal impairment. Patients with CKD on this combination warrant closer monitoring of both blood pressure and bupropion-related symptoms such as agitation, insomnia, or tremor.

Smoking cessation: patients starting bupropion (as Zyban) for smoking cessation while on lisinopril should be aware that nicotine withdrawal itself can transiently affect blood pressure, separate from any bupropion effect, and that the long-term cardiovascular benefit of quitting smoking is well established. Tracking blood pressure through the treatment course and for a few weeks after stopping bupropion is reasonable.

When to contact a prescriber

Contact the prescribing clinician if home blood pressure readings are consistently elevated above the individualized target discussed with your prescriber, if new headaches develop after starting or increasing bupropion, or if heart rate rises noticeably from baseline. Seek urgent care for symptoms of a hypertensive emergency, such as severe headache with vision changes, chest pain, shortness of breath, or confusion, or for a seizure, which requires immediate medical attention regardless of medication history.

What this page cannot tell you

This is general drug interaction information, not an individualized recommendation. It cannot tell you what dose is right for you, whether your specific blood pressure trend requires a medication change, or whether an alternative antidepressant is more appropriate for your situation. Those decisions depend on your full medical history and should be made with the clinician or pharmacist managing your care.